Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.

about

Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.

Item

http://www.wikidata.org/entity/Q47156816

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Procedures for the GMP-Complia ...... Detection of Prostate Cancer.

@en

Procedures for the GMP-Complia ...... Detection of Prostate Cancer.

@nl

type

Item

label

Procedures for the GMP-Complia ...... Detection of Prostate Cancer.

@en

Procedures for the GMP-Complia ...... Detection of Prostate Cancer.

@nl

prefLabel

Procedures for the GMP-Complia ...... Detection of Prostate Cancer.

@en

Procedures for the GMP-Complia ...... Detection of Prostate Cancer.

@nl

P1476

Procedures for the GMP-Complia ...... e Detection of Prostate Cancer

@en

P2093

Alexander Hoepping

http://www.w3.org/2001/XMLSchema#string

Anna-Maria Zerges

http://www.w3.org/2001/XMLSchema#string

Antje Hienzsch

http://www.w3.org/2001/XMLSchema#string

Heike Marx

http://www.w3.org/2001/XMLSchema#string

Klaus Kopka

http://www.w3.org/2001/XMLSchema#string

Klaus Weber

http://www.w3.org/2001/XMLSchema#string

Marco Müller

http://www.w3.org/2001/XMLSchema#string

Martin Schäfer

http://www.w3.org/2001/XMLSchema#string

Oliver C Neels

http://www.w3.org/2001/XMLSchema#string

Rene Smits

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.

New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients.

Preclinical Evaluation of 18F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging.

68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.

68Ga-prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Prostate Cancer Imaging: A Narrative Literature Review.

Radiofluorinated derivatives of 2-(phosphonomethyl)pentanedioic acid as inhibitors of prostate specific membrane antigen (PSMA) for the imaging of prostate cancer.

P31

scholarly article

P356

10.3390/PH10040077

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jens Cardinale

P577

2017-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28953234

http://www.w3.org/2001/XMLSchema#string

P921

quality control

P932

5748634

http://www.w3.org/2001/XMLSchema#string